A detailed history of Lindbrook Capital, LLC transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 113 shares of HCAT stock, worth $944. This represents 0.0% of its overall portfolio holdings.

Number of Shares
113
Holding current value
$944
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$5.48 - $8.83 $619 - $997
113 New
113 $0
Q2 2023

Jul 28, 2023

SELL
$9.86 - $13.12 $1,429 - $1,902
-145 Reduced 25.85%
416 $5,000
Q1 2023

Apr 26, 2023

SELL
$10.23 - $14.76 $583 - $841
-57 Reduced 9.22%
561 $6,000
Q4 2022

Jan 24, 2023

BUY
$6.86 - $11.32 $2,661 - $4,392
388 Added 168.7%
618 $0
Q3 2022

Nov 10, 2022

BUY
$9.3 - $18.27 $948 - $1,863
102 Added 79.69%
230 $2,000
Q2 2022

Aug 01, 2022

BUY
$11.79 - $27.63 $1,509 - $3,536
128 New
128 $2,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $457M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.